Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | FHD-286 |
Trade Name | |
Synonyms | FHD286|FHD 286 |
Drug Descriptions |
FHD-286 inhibits SMARCA4 (BRG1) and SMARCA2 (BRM), which may lead to altered chromatin accessibility and decreased tumor growth (Cancer Res 2022;82(12_Suppl):Abstract nr ND14, PMID: 38437498). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C179408 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Birabresib + FHD-286 | Birabresib FHD-286 | 1 | 0 |
Decitabine + FHD-286 | Decitabine FHD-286 | 1 | 0 |
FHD-286 | FHD-286 | 1 | 2 |
FHD-286 + Revumenib | FHD-286 Revumenib | 1 | 0 |
FHD-286 + Venetoclax | FHD-286 Venetoclax | 1 | 0 |